Go to Top

News & Events

Biomedal attended Biospain 2016

Biomedal has presented in Biospain 2016 the study published in The American Journal of Gastroenterology which reveals the level of compliance of the Gluten Free Diet (GFD) among celiac patients. The results of this first clinical trial, conducted by the University of Seville and Biomedal, a Spanish biotechnology company located in Seville, determined that more than 40% of celiac patients fail to adhere to the GFD involuntarily.

BioSpain is the largest international

Read More

More than 40% of celiac patients fail to adhere to the Gluten-free Diet

A research group of the University of Seville and Biomedal, a Spanish biotechnology company located in Seville, have studied the level of compliance of the Gluten Free Diet (GFD) among celiac patients. The results showed that more than 40% of celiac patients fail to adhere to this diet, at least once every 2-4 days.

The research was carried out thanks to a new analytic test which can detect gluten

Read More

Biomedal will introduce its new iVYDAL products at MEDICA

For the second consecutive year, Biomedal will attend again Medica, the World Forum for Medicine from 14th to 17th of November. Düsseldorf (Germany) will be the chosen place to internationally introduce the iVYDAL division of Biomedal Diagnostics, with its products for the adherence to the gluten free diet.

The iVYDAL division is made up of a line of several products: both iVYLISA GIP Stool and iVYCHECK GIP Stool are

Read More